Days at home for older adults receiving a remote monitoring intervention compared with usual home care recipients
Salahub C, Austin PC, Bai L, Ivers NM, Jones A, Tadrous M, Tran J, Lapointe-Shaw L. J Am Med Dir Assoc. 2025; 105611. Epub 2025 Apr 29.
Publications
Real-world comparative effectiveness and safety of pertuzumab in patients with HER2+ metastatic breast cancer: a pan-Canadian population-based cohort study
Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O’Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW; CanREValue Collaboration. Int J Cancer. 2025; Apr 23 [Epub ahead of print].
Trends in the cost and utilization of publicly reimbursed cancer medications dispensed as take-home treatments from 2017-2021
Garg R, Dumont T, McCormack D, Tadrous M, Campbell T, Chan K, Gomes T. Curr Oncol. 2025; 32(4):237.
Trends in the cost and utilization of publicly dispensed respiratory inhalers in Ontario, Canada: a repeated cross-sectional study
Garg R, Wang T, Tadrous M, Antoniou T, Gomes T. Pharmacoepidemiol Drug Saf. 2025; 34(4):e70125.
Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study
Iskandar RJ, Tadrous M, Nguyen P, Dolovich L, Green M, Frymire E, Drucker AM. Br J Dermatol. 2025; Apr 2 [Epub ahead of print].
Systemic therapies for psoriatic disease and serious infections in older adults
Drucker AM, Sutradhar R, Ling V, Gatley JM, Eder L, Fahim C, Fralick M, Gomes T, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. JAMA Dermatol. 2025; Mar 19 [Epub ahead of print].
Pathways of care following opioid overdose among people with opioid use disorder: a multilevel cohort study
Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Besharah J, Munro C, Campbell T, Gomes T. Drug Alcohol Depend. 2025; Mar 8 [Epub ahead of print].
Glucagon-like peptide 1 receptor agonists and risk of thyroid cancer: an international multisite cohort study
Baxter SM, Lund LC, Andersen JH, Brix TH, Hegedüs L, Hsieh MH, Su CT, Cheng MC, Chang ZC, Lai EC, Hussain S, Chu C, Gomes T, Antoniou T, Eskander A, Bouck Z, Tadrous M, Bea S, Choi EY, Shin JY, Modig K, Talbäck M, Ljung R, Gulseth HL, Karlstad Ø, Hicks B, Pottegård A. Thyroid. 2025; 35(1):69-78.
Impact of policy changes expanding access to direct-acting antivirals on hepatitis c virus-related hospitalizations in people with HIV: a population-based study
Antoniou T, Ledlie S, Wang T, Tadrous M, Gomes T. Open Forum Infect Dis. 2025; 12(1):ofaf003.
COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: a Canadian immunization research network (CIRN) study
Piché-Renaud PP, Drover SSM, Austin PC, Morris SK, Buchan SA, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson SE, Wilson K, Guttmann A, Kwong JC. Vaccine. 2024; Nov 30 [Epub ahead of print].